Latest Regulatory Decisions News

The Takeovers Panel has declined to investigate Global Lithium Resources Limited's claims of undisclosed shareholder associations ahead of its AGM, citing untimeliness and lack of merit.

Bubs Australia has reported a strong Q2 FY25 performance with a positive EBITDA turnaround and robust revenue growth, while advancing its critical FDA clinical trial in the US.

Telix Pharmaceuticals has exceeded its full-year 2024 revenue guidance, driven by strong sales of its prostate cancer diagnostic Illuccix® and strategic pipeline advancements.